PMID- 27988444 OWN - NLM STAT- MEDLINE DCOM- 20170707 LR - 20181202 IS - 1879-0852 (Electronic) IS - 0959-8049 (Linking) VI - 71 DP - 2017 Jan TI - Regional and inter-hospital differences in the utilisation of liver surgery for patients with synchronous colorectal liver metastases in the Netherlands. PG - 109-116 LID - S0959-8049(16)32532-1 [pii] LID - 10.1016/j.ejca.2016.10.026 [doi] AB - BACKGROUND: The objective of this study was to map referral patterns in patients with synchronous colorectal liver metastases (SCLM) and to investigate if type, volume and location of the hospital of diagnosis are associated with whether or not patients underwent liver resection. METHODS: This population-based study includes all patients diagnosed with SCLM between 2008 and 2012, based on the Netherlands Cancer Registry. To study inter-hospital variation, the proportion of patients undergoing liver surgery was calculated per hospital of diagnosis. Multivariable multilevel logistic regression analysis was used to investigate the association between hospital characteristics and liver resection. RESULTS: Of 10,520 patients with SCLM, 12% (n = 1259) underwent liver surgery. Of these patients, 58% (n = 733) were referred to another hospital to undergo liver surgery. In 53% of the patients (n = 647), liver resection was performed in a university hospital, in 39% (n = 482) in a dedicated liver centre and in 8% (n = 102) in a general hospital. There was a large inter-hospital variation in the proportion of patients undergoing liver resection (2-26%). In a multilevel logistic regression model, the odds of undergoing liver surgery were higher when patients were diagnosed in hospitals where liver surgery was performed compared with the general hospitals (dedicated liver centre: odds ratio 1.36 [95% confidence intervals 1.08-1.70], university hospital: odds ratio 1.69 [95% confidence intervals 1.22-2.34]). CONCLUSION: There is a large inter-hospital and inter-regional variation in the utilisation of liver resection. Patients diagnosed with SCLM in expert centres had a higher chance of undergoing liver resection. CI - Copyright (c) 2016 Elsevier Ltd. All rights reserved. FAU - 't Lam-Boer, J AU - 't Lam-Boer J AD - Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Jorine.tLam-Boer@radboudumc.nl. FAU - van der Stok, E P AU - van der Stok EP AD - Division of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. FAU - Huiskens, J AU - Huiskens J AD - Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands. FAU - Verhoeven, R H A AU - Verhoeven RH AD - Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands. FAU - Punt, C J A AU - Punt CJ AD - Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands. FAU - Elferink, M A G AU - Elferink MA AD - Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands. FAU - de Wilt, J H AU - de Wilt JH AD - Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands. FAU - Verhoef, C AU - Verhoef C AD - Division of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. CN - CAIRO5/CHARISMA Group LA - eng PT - Journal Article DEP - 20161216 PL - England TA - Eur J Cancer JT - European journal of cancer (Oxford, England : 1990) JID - 9005373 SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Colorectal Neoplasms/*pathology MH - Female MH - Hepatectomy/*statistics & numerical data MH - Hospitals/*statistics & numerical data MH - Humans MH - Liver Neoplasms/*secondary/*surgery MH - Logistic Models MH - Male MH - Middle Aged MH - Netherlands MH - Practice Patterns, Physicians'/*statistics & numerical data OTO - NOTNLM OT - Colorectal cancer OT - Inter-hospital differences OT - Liver metastases OT - Liver surgery OT - Stage IV FIR - Dejong, C H C IR - Dejong CH IRAD- Maastricht University Medical Center, Maastricht, The Netherlands. FIR - Grunhagen, D IR - Grunhagen D IRAD- Erasmus MC Cancer Institute, Rotterdam, The Netherlands. FIR - van Gulik, T M IR - van Gulik TM IRAD- Academic Medical Center, Amsterdam, The Netherlands. FIR - de Jong, K P IR - de Jong KP IRAD- University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. FIR - Kazemier, G IR - Kazemier G IRAD- VU University Medical Centre, Amsterdam, The Netherlands. FIR - Molenaar, I Q IR - Molenaar IQ IRAD- University Medical Center Utrecht, Utrecht, The Netherlands. FIR - Ruers, T M IR - Ruers TM IRAD- Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. EDAT- 2016/12/19 06:00 MHDA- 2017/07/08 06:00 CRDT- 2016/12/19 06:00 PHST- 2016/04/19 00:00 [received] PHST- 2016/10/12 00:00 [revised] PHST- 2016/10/21 00:00 [accepted] PHST- 2016/12/19 06:00 [pubmed] PHST- 2017/07/08 06:00 [medline] PHST- 2016/12/19 06:00 [entrez] AID - S0959-8049(16)32532-1 [pii] AID - 10.1016/j.ejca.2016.10.026 [doi] PST - ppublish SO - Eur J Cancer. 2017 Jan;71:109-116. doi: 10.1016/j.ejca.2016.10.026. Epub 2016 Dec 16.